NGM Biopharmaceuticals • NGM
NGM Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company.
Ratings
1 / 5
1 rating in the last 12 months
5
4
3
2
1
CEO
Dr. David J. Woodhouse, PhD$128.5M
Market Cap • 05/04/20242007
(há 17 anos)
2019
(5 years ago)
NASDAQ
Listagem
South San Francisco
Sede • California239
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
NGMSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.